Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a
Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic interventions for Alzheimer's disease, Parkinson's disease and orphan ophthalmological disorders, today announced positive 15-day non-GLP toxicology data for a single intravitreal administration of MANF in an ocular safety animal model, relevant to MANF's development in ocular diseases, including orphan indications such as Retinitis Pigmentosa. The intravitreal method of administration was chosen because it is the delivery method expected for human application of MANF. The experiments were conducted at a leading ophthalmology contract research laboratory in France.
"We are pleased to see continued progress in our orphan program for MANF in ophthalmological diseases," said Gerald E. Commissiong, President & CEO of Amarantus. "The results seen in this ocular tolerance study are encouraging for an initial clinical focus on MANF in orphan ocular diseases. This data will support the preparation of our orphan drug designation application with the FDA for MANF in one or more ocular disorders in the fourth quarter, including Retinitis Pigmentosa."
The aim of this study was to evaluate the ocular tolerance of MANF after a single intravitreal administration in pigmented rabbits over a 15 day period at dosing levels expected to be above therapeutically relevant dosing levels in human. Ten female pigmented rabbits were divided in two groups of five animals each, corresponding to treatment with MANF and treatment with vehicle (control). MANF and the vehicle were dosed by intravitreal injection in the right eye once, on Day 1. Slit-lamp examinations on four days during the 15-day follow-up period were complemented with a histopathology evaluation of the treated eyes on day 15. There were no treatment or administration-related effects on body weight, clinical observations or ophthalmic examinations. No pathological findings related to treatment were found in any of the eyes observed during histopathology evaluation. The report from the study concluded that a single intravitreal administration of MANF in pigmented rabbits was macroscopically and microscopically very well tolerated.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Cultural Tapestry Unfurls in Putian Picture this: a kaleidoscope of cultures and ideas unraveling in the coastal city of Putian. The 11th Global Mazu Culture Forum kicks off on October 31, bringing together minds—both fresh and seasoned—from an impressive array of 47 countries and regions. It's more than a forum; it's a vibrant crossroads of innovation, tradition,...
Continue Reading
Bankrolling Hope: FirstEnergy's $115K Commitment On the surface, corporate philanthropy sounds like yet another PR stunt, but sometimes these dollars pour a lifeline for those in dire need. Today, we look at FirstEnergy Foundation throwing a weighty $115,000 towards ensuring Pennsylvanians have stable roofs over their heads. This isn't your garden-variety donation—a lot...
Continue Reading
A Legal Powerhouse Expands Its Reputation Just when you think you've got the legal market pegged, something like this pops up: Greenberg Traurig's 93 attorneys make it onto the coveted 2026 New York Metro Super Lawyers lists. We're talking about 59 making the 'Super Lawyers' list and 34 slipping into the 'Rising Stars' category. They even had Vice Chairman Robert J....
Continue Reading
Breaking the Fear of the Dentist's Chair There's no sugar-coating it—hitting the dental chair can feel like gearing up for a bout in the boxing ring, especially if anxiety's already taken root. But listen, it doesn't have to be that way, and that's where HelloNation's recent feature steps in. Dr. Adriane Lippian and Dr. Jim Lippian, dentists hailing from Texarkana,...
Continue Reading
Celebrating a Beachside Milestone Out there in the sun-soaked corners of Cancun, it's another sunburnt milestone for the folks over at Sunset Royal Beach Resort. We're talking a full 32 years of greeting guests with their signature tropical flair. Now that's the kind of longevity you just don't find in today's fleeting hospitality market. A pat on the back to any...
Continue Reading
Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...
Continue Reading
Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...
Continue Reading
Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....
Continue Reading
Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...
Continue Reading
Intersecting Paths in the Amazon Deep in the heart of the Amazon, where Colombia meets Brazil and Peru, something unique is happening. The Scientology Volunteer Ministers, amid their Amazon Extreme Pioneer Tour, have joined forces with the Colombian Red Cross and the Correcaminos Foundation to host a community outreach event near Leticia. This isn’t some fly-by-night...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Rise of Unauthorized AI Usage in Workplaces The study highlights a significant trend as corporate trust dwindles. UpGuard, a recognized leader in cybersecurity and risk management, has recently released a study titled "State of Shadow AI". This report uncovers the troubling prevalence of unapproved generative AI tools being employed within various...
Continue Reading
Support for Quality Afterschool Programs Grows Stronger Recently, over 100 students, educators, program professionals, community leaders, and legislators gathered to advocate for enhanced funding for quality afterschool programs at the annual Afterschool Advocacy Day held at the State Capitol. This collective effort underscores the vital role that afterschool initiatives...
Continue Reading
Strengthening Leadership at Associated Bank Associated Banc-Corp ASB has made notable strides in its leadership structure by announcing the inclusion of Phillip Trier and Gregory Warsek into its Executive Leadership Team (ELT). Their appointments signal a strategic move to enhance operational capability and market growth within the banking sector. Phillip Trier Appointed...
Continue Reading
Home BancShares, Inc. Earnings Release Announcement Home BancShares, Inc. (NYSE: HOMB), which is the parent company of Centennial Bank, will announce its third-quarter earnings after the market closes on a soon-to-be-announced date. Investors and analysts are looking forward to seeing these results, as they will shed light on the bank's operational achievements and...
Continue Reading
VeraBIND Tau Assay: A Pioneering Approach to Alzheimer's Detection Veravas Inc. has taken a significant step forward in the realm of diagnostics with its introduction of the VeraBIND™ Tau Assay, a groundbreaking blood test designed to detect pathologically active tau. This innovative test aims to identify Alzheimer's disease in both asymptomatic and symptomatic...
Continue Reading